Clinical Trial Update: Galantamine for Cognition in People With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating galantamine for cognitive improvement in people with schizophrenia or schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED